The success of AI is going to require cooperation of academics and leaders in AI outside of medicine — from Microsoft, Google and Nvidia, says radiologist Elliot Fishman, who launched a popular speaker series at Johns Hopkins, “Leading Change: Perspectives from Outside Medicine,” 10 years ago.

“We have the problems, we have the data and they have the solutions. Neither will succeed without the other,” Fishman predicts. A harbinger of things to come: “The New England Journal of Medicine, which for 100-plus years would never publish an article from someone from a company, recently ran an article on AI and ChatGPT. The first two authors were from Microsoft. The third was from Nuance, which is owned by Microsoft.

“Our patients are reading and hearing about AI and its accuracy, and they are expecting us to use it. That’s the good news and the challenge,” says Fishman. “Most scientific discoveries start at places like Hopkins, and then it takes a bunch of years to get down into their community hospitals. But AI is breaking all the rules. Now, all of a sudden, you have the private practices getting involved with AI before the academic institutions.”